Clinical Trial Update: Safety and Tolerability of Repeat Courses of IM Alefacept [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports safety and tolerability data for repeat courses of IM alefacept in chronic plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Amevive (alefacept)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Chronic Plaque Psoriasis | Phase 4 | Status: COMPLETED